Seizert Capital Partners LLC increased its position in shares of CVS Health Corporation (NYSE:CVS) by 3.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 556,649 shares of the pharmacy operator’s stock after purchasing an additional 16,177 shares during the quarter. CVS Health Corporation accounts for approximately 1.6% of Seizert Capital Partners LLC’s investment portfolio, making the stock its 23rd largest holding. Seizert Capital Partners LLC owned 0.05% of CVS Health Corporation worth $44,788,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Horan Capital Advisors LLC. lifted its holdings in shares of CVS Health Corporation by 3.2% during the second quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock worth $2,584,000 after purchasing an additional 1,000 shares during the period. Community Bank N.A. lifted its holdings in shares of CVS Health Corporation by 7.3% during the second quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock worth $1,608,000 after purchasing an additional 1,362 shares during the period. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of CVS Health Corporation by 3.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after purchasing an additional 5,478 shares during the period. Midwest Investment Management LLC lifted its holdings in shares of CVS Health Corporation by 6.2% during the second quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock worth $1,720,000 after purchasing an additional 1,245 shares during the period. Finally, Fiduciary Trust Co. raised its position in CVS Health Corporation by 1.2% during the first quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock valued at $28,732,000 after acquiring an additional 4,265 shares in the last quarter. 82.04% of the stock is owned by hedge funds and other institutional investors.
Several research analysts recently weighed in on the company. BidaskClub upgraded CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 2nd. Citigroup Inc. reduced their price target on CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating for the company in a research report on Thursday, August 17th. Royal Bank Of Canada started coverage on CVS Health Corporation in a research report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price target for the company. Jefferies Group LLC boosted their price objective on CVS Health Corporation from $82.00 to $86.00 and gave the company a “hold” rating in a research report on Friday, September 15th. Finally, Wolfe Research cut CVS Health Corporation from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $89.00 to $82.00 in a research report on Monday, August 14th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $85.82.
WARNING: “CVS Health Corporation (CVS) Holdings Raised by Seizert Capital Partners LLC” was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://ledgergazette.com/2017/11/17/cvs-health-corporation-cvs-holdings-raised-by-seizert-capital-partners-llc.html.
In other news, COO Jonathan C. Roberts sold 85,743 shares of the stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $83.14, for a total value of $7,128,673.02. Following the transaction, the chief operating officer now owns 119,555 shares in the company, valued at approximately $9,939,802.70. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO David M. Denton sold 237,078 shares of the stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.65, for a total value of $18,883,262.70. Following the completion of the transaction, the chief financial officer now owns 141,096 shares in the company, valued at approximately $11,238,296.40. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 714,125 shares of company stock worth $58,119,381. 0.61% of the stock is owned by company insiders.
Shares of CVS Health Corporation (NYSE:CVS) opened at $70.26 on Friday. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $70,706.84, a price-to-earnings ratio of 12.22, a P/E/G ratio of 1.20 and a beta of 0.86. CVS Health Corporation has a 1-year low of $66.45 and a 1-year high of $84.72.
CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion for the quarter, compared to the consensus estimate of $46.17 billion. CVS Health Corporation had a return on equity of 16.96% and a net margin of 2.77%. The company’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.64 EPS. research analysts forecast that CVS Health Corporation will post 5.9 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th were issued a dividend of $0.50 per share. The ex-dividend date was Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.85%. CVS Health Corporation’s dividend payout ratio (DPR) is 41.32%.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.